Sensory Neuropathy - Pipeline Insight, 2019 by Developmental Stage, Associated Indications, Route of Administration, and Molecule Type - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 31, 2019--The “Sensory Neuropathy - Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Sensory Neuropathy - Pipeline Insight, 2019 offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Sensory Neuropathy development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline Products covered across the following Developmental Stages:Clinical Non-clinical Inactive: Discontinued and/or Dormant
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
ScopeThe report provides a snapshot of the pipeline development for the Sensory Neuropathy The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Sensory Neuropathy The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Sensory Neuropathy The report also covers the dormant and discontinued pipeline projects related to Sensory Neuropathy
1. Report Introduction
2. Sensory Neuropathy Overview
3. Pipeline TherapeuticsAn Overview of Pipeline Products for Sensory Neuropathy
4. Comparative Analysis
5. Products in Clinical StageProduct Description Research and Development Product Development Activities
6. Products in Pre-Clinical and Discovery StageProduct Description Research and Development Product Development Activities
7. Therapeutic AssessmentAssessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type
8. Inactive ProductsProduct Description Research and Development Product Development Activities
Companies FeaturedAraim Pharmaceuticals CSL Limited GeNeuro SA Mitsubishi Tanabe Pharma Corporation Neuren Pharmaceuticals Limited Pfizer Inc. Pharnext SAS Polyneuron Pharmaceuticals AG RegeneRx Biopharmaceuticals Sanofi Shire PLC Teijin Pharma Limited
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/rhr9qw/sensory?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190131005743/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Central Nervous System Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/31/2019 12:30 PM/DISC: 01/31/2019 12:30 PM